Literature DB >> 22036518

Twenty-nine cases of invasive aspergillosis in neutropenic patients.

F Saghrouni1, Y Ben Youssef, S Gheith, Z Bouabid, J Ben Abdeljelil, I Khammari, A Fathallah, A Khlif, M Ben Saïd.   

Abstract

INTRODUCTION: Invasive aspergillosis is a life-threatening infectious complication in hematological patients undergoing immunosuppressive chemotherapy. PATIENTS AND METHODS: We report 29 cases of invasive aspergillosis diagnosed in the Sousse Farhat Hached hospital Hematology unit, Tunisia, between 2002 and 2010.
RESULTS: The most frequent disease (65.5%) was acute myeloid leukemia. All patients were severely neutropenic (<500/mm(3), mean duration=27 days). Pulmonary invasive aspergillosis was suggested in 28 (96.5%) cases. The most frequent respiratory signs were cough (64.3%), chest pain (53.6%), and hemoptysis (50%). The chest X-ray showed suggestive lesions in 60.7% of cases. CT scans revealed nodules with cavitation in 65% of cases, a halo sign in 20% of cases, and nodules in 15% of cases. Galactomannan antigenemia was positive in 88%, mycological examination positive in 51.6%, and seroconversion was noted in 35.7% of the cases. Invasive pulmonary aspergillosis was classified, according to EORTC/MSG criteria, as probable in 26 cases, possible in one case, and proven in one case. Aspergillus flavus was the dominant species in pulmonary invasive aspergillosis accounting for 73.7% of isolates. Extrapulmonary involvement was suggested in 39.3% of cases, the most frequent were sinusitis and brain abscess. Primary cutaneous aspergillosis was observed in one case. The overall mortality rate was 64.2%; the 12-week survival rate was 71.4%.
CONCLUSION: Our results are correlated to published data. A. flavus was the most frequent species in our region.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036518     DOI: 10.1016/j.medmal.2011.09.011

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  12 in total

1.  Primary cutaneous aspergillosis and idiopathic bone marrow aplasia.

Authors:  Karina Colossi Furlan; Mario Cezar Pires; Priscila Kakizaki; Juliana Cabral Nunes Chartuni; Neusa Yuriko Sakai Valente
Journal:  An Bras Dermatol       Date:  2016 May-Jun       Impact factor: 1.896

Review 2.  Role of microglia in fungal infections of the central nervous system.

Authors:  George W Koutsouras; Raddy L Ramos; Luis R Martinez
Journal:  Virulence       Date:  2016-11-18       Impact factor: 5.882

3.  Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis.

Authors:  Mojtaba Taghizadeh-Armaki; Mohammad T Hedayati; Vahid Moqarabzadeh; Saham Ansari; Saeed Mahdavi Omran; Hossein Zarrinfar; Sasan Saber; Paul E Verweij; David W Denning; Seyedmojtaba Seyedmousavi
Journal:  J Med Microbiol       Date:  2017-07-12       Impact factor: 2.472

4.  Burden of fungal infections in Algeria.

Authors:  M Chekiri-Talbi; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-21       Impact factor: 3.267

5.  Acute Invasive Fungal Rhinosinusitis: A Comprehensive Update of CT Findings and Design of an Effective Diagnostic Imaging Model.

Authors:  E H Middlebrooks; C J Frost; R O De Jesus; T C Massini; I M Schmalfuss; A A Mancuso
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-16       Impact factor: 3.825

6.  Epidemiology of Aspergillosis in Cancer Patients in Taiwan.

Authors:  Chien-An Chen; Chung-Han Ho; Yu-Cih Wu; Yi-Chen Chen; Jhi-Joung Wang; Kuang-Ming Liao
Journal:  Infect Drug Resist       Date:  2022-07-13       Impact factor: 4.177

Review 7.  Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach.

Authors:  S Moura; L Cerqueira; A Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-13       Impact factor: 3.267

8.  Immunobiological Activity of Synthetically Prepared Immunodominant Galactomannosides Structurally Mimicking Aspergillus Galactomannan.

Authors:  Ema Paulovičová; Lucia Paulovičová; Martin Hrubiško; Vadim B Krylov; Dmitry A Argunov; Nikolay E Nifantiev
Journal:  Front Immunol       Date:  2017-10-13       Impact factor: 7.561

9.  A model for classification of invasive fungal rhinosinusitis by computed tomography.

Authors:  Guy Slonimsky; Johnathan D McGinn; Neerav Goyal; Henry Crist; Max Hennessy; Eric Gagnon; Einat Slonimsky
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

Review 10.  Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis.

Authors:  Mingxiang Zou; Lanhua Tang; Shushan Zhao; Zijin Zhao; Luyao Chen; Peng Chen; Zebing Huang; Jun Li; Lizhang Chen; Xuegong Fan
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.